Sodium thiosulfate delays the progression of coronary artery calcification in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 25, Issue 6, 2010, Pages 1923-1929

  Adirekkiat, Surawat ^a   Sumethkul, Vasant ^a   Ingsathit, Atiporn ^a   Domrongkitchaiporn, Somnuek ^a   Phakdeekitcharoen, Bunyong ^a   Kantachuvesiri, Surasak ^a   Kitiyakara, Chagriya ^a   Klyprayong, Pinkaew ^a   Disthabanchong, Sinee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Bone; Haemodialysis; Sodium thiosulfate; Treatment; Vascular calcification

Indexed keywords

ALFACALCIDOL; CALCITRIOL; PHOSPHATE; SODIUM THIOSULFATE;

ADULT; AGED; ANION GAP; ANOREXIA; ARTERY CALCIFICATION; ARTICLE; BONE DEMINERALIZATION; BONE DENSITY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; DIZZINESS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HEMODIALYSIS; HIP; HUMAN; HYPOTENSION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; SNEEZING; SODIUM BLOOD LEVEL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

AGED; BONE DENSITY; CALCINOSIS; CHELATING AGENTS; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; THIOSULFATES;

EID: 77952983286     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp755     Document Type: Article

References (39)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112-S119
2. Arad Y, Goodman KJ, Roth M et al. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 2005; 46: 158-165
3. Stompor T, Pasowicz M, Sullowicz W et al. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 2003; 41: 203-211
4. Raggi P, Boulay A, Chasan-Taber S et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 39: 695-701
5. Nitta K, Akiba T, Suzuki K et al. Effects of cyclic intermittent etidro-nate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 2004; 44: 680-688
6. Matsuoka M, Iseki K, Tamashiro M et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004; 8: 54-58
7. London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740
8. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483
9. Baskin SI, Horowitz AM, Nealley EW. The antidotal action of sodium nitrite and sodium thiosulfate against cyanide poisoning. J Clin Pharmacol 1992; 32: 368-375
10. Brucculeri M, Cheigh J, Bauer G et al. Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Semin Dial 2005; 18: 431-434
11. Cicone JS, Petronis JB, Embert CD et al. Successful treatment of cal-ciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 2004; 43: 1104-1108
12. Araya CE, Fennell RS, Neiberger RE et al. Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol 2006; 1: 1161-1166
13. Kyriakopoulos G, Kontogianni K. Sodium thiosulfate treatment of tumoral calcinosis in patients with end-stage renal disease. Ren Fail 1990; 12: 213-219
14. YatzidisH.Absenceordecreased endogenous thiosulfaturia: a cause of recurrent calcium nephrolithiasis. Int Urol Nephrol 2004; 36: 587-589
15. Karageuzyan KG. Oxidative stress in the molecular mechanism of pathogenesis at different diseased states of organism in clinics and experiment. Curr Drug Targets Inflamm Allergy 2005; 4: 85-98
16. Pasch A, Schaffner T, Huynh-Do U et al. Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int 2008; 74: 1444-1453
17. Agatston AS, Janowitz WR, Hildner FJ et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832
18. Brandi L, Egfjord M, Olgaard K. Comparison between 1alpha(OH) D3 and 1, 25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays. Nephron Clin Pract 2005; 99: c128-c137
19. Moe S, Wazny LD, Martin JE. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial. Can J Clin Pharmacol 2008; 15: e36-e43
20. Kiattisunthorn K, Indranoi A, Wutyam K et al. Oral calcitriol versus oral alfacalcidol for treatment of secondary hyperparathyroidism in chronic hemodialysis patients: a randomized single-blinded controlled trial. J Am Soc Nephrol 2009; 20: 259A-260A
21. Callister TQ, Cooil B, Raya SP et al. Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 1998; 208: 807-814
22. Hokanson JE, MacKenzie T, Kinney G et al. Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. AJR Am J Roentgenol 2004; 182: 1327-1332
23. Jung HH, Kim SW, Han H. Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialy-sis. Nephrol Dial Transplant 2006; 21: 1915-1920
24. Asplin JR, Donahue SE, Lindeman C et al. Thiosulfate reduces calcium phosphate nephrolithiasis. J Am Soc Nephrol 2009; 20: 1246-1253
25. Mataic D, Bastani B. Intraperitoneal sodium thiosulfate for the treatment of calciphylaxis. Ren Fail 2006; 28: 361-363
26. Mendoza FJ, Lopez I, Montes de Oca A et al. Metabolic acidosis inhibits soft tissue calcification in uremic rats. Kidney Int 2008; 73: 407-414
27. Nitta K, Akiba T, Uchida K et al. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term he-modialysis. Am J Kidney Dis 2003; 42: 303-309
28. Chertow GM, Raggi P, Chasan-Taber S et al. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1489-1496
29. London GM, Marty C, Marchais SJ et al. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004; 15: 1943-1951
30. Galassi A, Spiegel DM, Bellasi A et al. Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialy-sis diabetic patients receiving calcium binders. Nephrol Dial Transplant 2006; 21: 3215-3222
31. Barreto DV, Barreto Fde C, Carvalho AB et al. Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study. Am J Kidney Dis 2008; 52: 1139-1150
32. Sigrist MK, Taal MW, Bungay P et al. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 1241-1248
33. Civilibal M, Caliskan S, Kurugoglu S et al. Progression of coronary calcification in pediatric chronic kidney disease stage 5. Pediatr Nephrol 2009; 24: 555-563
34. Qunibi W, Moustafa M, Muenz LR et al. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study. Am J Kidney Dis 2008; 51: 952-965
35. Patsalas S, Eleftheriadis T, Theodoroglou H et al. Coronary artery calcification, coronary artery stenosis and hyperphosphatemia in hemodialysis patients. Ther Apher Dial 2007; 11: 81author reply 2
36. Bushinsky DA, Lechleider RJ. Mechanism of proton-induced bone calcium release: calcium carbonate-dissolution. Am J Physiol 1987; 253: F998-F1005
37. Kraut JA, Mishler DR, Singer FR et al. The effects of metabolic acidosis on bone formation and bone resorption in the rat. Kidney Int 1986; 30: 694-700
38. Disthabanchong S, Domrongkitchaiporn S, Sirikulchayanonta Vet al. Alteration of noncollagenous bone matrix proteins in distal renal tubular acidosis. Bone 2004; 35: 604-613
39. Tokashiki K, Ishida A, Kouchi M et al. Successful management of critical limb ischemia with intravenous sodium thiosulfate in a chronic hemodialysis patient. Clin Nephrol 2006; 66: 140-143